ScholarIQanswers from OpenAlex
European School of Oncology
InstitutionResearch output, impact & collaborations
European School of Oncology is a institution indexed in ScholarIQ from OpenAlex.
What is known about European School of Oncology?
ScholarIQrecord summary
European School of Oncology is a research organisation in Milan, IT. OpenAlex records 593 works and 54,777 citations for it. 101 researchers list it as their most recent affiliation.
How many works does European School of Oncology have?
ScholarIQindexed works
European School of Oncology has 593 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does European School of Oncology have?
ScholarIQcitation count
European School of Oncology has 54,777 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at European School of Oncology?
ScholarIQresearcher count
European School of Oncology has 101 researchers in the ScholarIQ index.
What is the average h-index at European School of Oncology?
ScholarIQavg h-index
European School of Oncology has an average h-index of 157 in OpenAlex.
What is the ROR of European School of Oncology?
ScholarIQror
The ROR for European School of Oncology is on the source record.
What is the OpenAlex record for European School of Oncology?
ScholarIQopenalex
The OpenAlex for European School of Oncology is on the source record.
Who are the most-cited researchers behind European School of Oncology?
ScholarIQtop researchers by citations
What are the most-cited papers on European School of Oncology?
ScholarIQmost cited works
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen, Giancarlo Pruneri, Stephan Wienert, Gert Van den Eynden, Frederick L. Baehner, Frédérique Penault‐Llorca, Edith A. Perez, E. Aubrey Thompson, W. Fraser Symmans, Andrea L. Richardson, Jane Brock, Carmen Criscitiello, Helen D. Bailey, M. Ignatiadis, Giuseppe Floris, Joseph A. Sparano, Zuzana Kos, Torsten O. Nielsen, David L. Rimm, Kimberly H. Allison, Jorge S. Reis‐Filho, Sibylle Loibl, Christos Sotiriou, Giuseppe Viale, Sunil Badve, Sylvia Adams, Karen Willard‐Gallo, Sherene Loi
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean‐Yves Pierga, Étienne Brain, Sylvain Causeret, Mauro Delorenzi, Annuska M. Glas, Vassilis Golfinopoulos, Theodora Goulioti, Susan Knox, Erika Matos, Bart Meulemans, Peter A. Neijenhuis, Ulrike Nitz, Rodolfo Passalacqua, Peter M. Ravdin, Isabel T. Rubio, Mahasti Saghatchian, Tineke J. Smilde, Christos Sotiriou, Lisette Stork, Carolyn Straehle, Geraldine Thomas, Alastair M. Thompson, Jacobus M. van der Hoeven, Peter Vuylsteke, René Bernards, Konstantinos Tryfonidis, Emiel J. Rutgers, Martine Piccart
Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer
Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett, Shannon McKernin, Lisa A. Carey, Patrick L. Fitzgibbons, Daniel F. Hayes, Sunil R. Lakhani, Mariana Chávez‐MacGregor, Jane Perlmutter, Charles M. Perou, Meredith M. Regan, David L. Rimm, W. Fraser Symmans, Emina Torlakovic, Leticia Varella, Giuseppe Viale, Tracey Weisberg, Lisa M. McShane, Antonio C. Wolff
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Fabio Conforti, Laura Pala, Vincenzo Bagnardi, Tommaso De Pas, Marco Martinetti, Giuseppe Viale, Richard D. Gelber, Aron Goldhirsch
How much of the research on European School of Oncology is open access?
ScholarIQopen access share
67%OPEN ACCESS